The EPLINα isoform has been implicated in the progression of various cancers, and this was initially recognised in oral cancer, breast, prostate and xenograft tumours where EPLIN expression was either downregulated or completely abolished [4]. This evidence concerns the gene LIMA1 and neoplasm.